Sunday, August 25, 2013

The end of summer doldrums

With a week left in August, perhaps the summer doldrums are coming to an end for my portfolio companies (and the market as a whole). My holdings have been trading in a range for many weeks, so I'm hoping for positive catalysts soon to break my biotechs out of that range to the upside.  There are some medical conferences coming in the next 1-2 months which may do just that, provided the clinical data presented is sufficiently strong.